Perhaps the people at Vertex are saying “I could have been a contender”.  Vertex Pharmaceuticals had a brief moment in the sun with its hepatitis C drug, and now that it’s coming to an end, the company is making some big job cuts.  What went wrong is a failure of key market research insights and a belief that the whole world would beat a path to their door when they launched the Hep-C drug. The end result is that Vertex is laying off 350 people because sales are below expectations.